Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Product revenue $ 2,291,000 $ 2,629,000
Costs of revenue 524,000 661,000
Gross profit 1,767,000 1,968,000
Operating expenses:    
Research and development 1,239,000 1,016,000
General and administrative 1,474,000 1,112,000
Sales and marketing 1,198,000 1,642,000
Total operating expenses 3,911,000 3,770,000
Loss from operations (2,144,000) (1,802,000)
Other income (expenses):    
Interest expense (476,000) (360,000)
Loss on extinguishment of debt (340,000)
Change in fair value of derivative liabilities 811,000 1,780,000
Loss on extinguishment of derivative liabilities (1,252,000)
Offering costs (131,000)
Other income, net 2,000 1,000
Total other income (expense), net (1,255,000) 1,290,000
Net loss before income taxes (3,399,000) (512,000)
Provision for income taxes
Net loss (3,399,000) (512,000)
Deemed dividend related to adjustment of the exercise price of warrants issued with debt (9,000)
Net loss attributable to common stockholders $ (3,408,000) $ (512,000)
Net loss per share    
Basic and diluted $ (1.00) $ (0.18)
Weighted average common shares outstanding:    
Basic and diluted 3,411,246 2,826,469